Biodistribution, Imaging Properties, and Radiation Dosimetry of [18F]-GP1 Positron Emission Tomography (PET) Tracer in Vascular Disease Imaging

Trial Profile

Biodistribution, Imaging Properties, and Radiation Dosimetry of [18F]-GP1 Positron Emission Tomography (PET) Tracer in Vascular Disease Imaging

Discontinued
Phase of Trial: Phase I

Latest Information Update: 12 May 2017

At a glance

  • Drugs 18F GP1 (Primary)
  • Indications Abdominal aortic aneurysm; Deep vein thrombosis
  • Focus Diagnostic use; First in man
  • Most Recent Events

    • 08 May 2017 Status changed from recruiting to discontinued.
    • 26 Oct 2016 Planned End Date changed from 1 Jul 2016 to 1 Dec 2016.
    • 26 Oct 2016 Planned primary completion date changed from 1 Jul 2016 to 1 Dec 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top